KGMU urology scam: Medicines worth ₹5 lakh recovered from dismissed staffers’ lockers

The KGMU spokesperson said the inquiry committee is reconciling the recovered medicines with purchase and stock records

The probe into the multi-crore medicine scam in the KGMU Urology department intensified on Monday after the inquiry committee recovered medicines worth nearly 3 lakh from three lockers belonging to dismissed contractual employees. Earlier, medicines worth around 2 lakh had been found in another dismissed employee’s locker, taking the total recovery to about 5 lakh.

KGMU spokesperson Dr KK Singh said the inquiry committee is reconciling the recovered medicines with purchase and stock records, and action will be taken against any employee or official found involved in the irregularities.

The committee has seized the medicines and started matching them with procurement, stock and distribution records. Preliminary findings suggest the medicines were purchased under government-funded schemes, including Ayushman Bharat Yojna, the Chief Minister Relief Fund, the Prime Minister Relief Fund, and the Asadhya Yojana, but were found in employees’ lockers instead of reaching the patients.

The scam, involving medicines worth around 1.5 crore, has already led to the dismissal of three contractual employees, suspension of one pharmacist, removal of the Head of the Urology Department.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’